Stay updated on Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.5.2 to v3.5.3, indicating a backend/site release rather than a modification to the clinical trial’s record history or study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:44:46.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:32:53.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added Study Design and Study Status entries in the latest history versions; a previous entry dated 2026-03-05 was removed.
    Difference
    0.5%
    Check dated 2026-04-02T15:23:15.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:58:36.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added a new Study Status entry to the record history and updated the record to revision v3.4.3 on 2026-03-05.
    Difference
    0.5%
    Check dated 2026-03-12T00:38:19.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the lapse-in-government-funding notice and the prior Revision: v3.4.1 from the history.
    Difference
    0.8%
    Check dated 2026-02-11T11:51:34.000Z thumbnail image

Stay in the know with updates to Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.